Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 194 citing articles:

Traditional and non-traditional uses of Mitragynine (Kratom): A survey of the literature
Darshan Singh, Suresh Narayanan, Balasingam Vicknasingam
Brain Research Bulletin (2016) Vol. 126, pp. 41-46
Closed Access | Times Cited: 187
An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
Christopher R. McCurdy, Abhisheak Sharma, Kirsten E. Smith, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 131-142
Closed Access | Times Cited: 18
Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives
Giovanni Martinotti, Rita Santacroce, Mauro Pettorruso, et al.
Brain Sciences (2018) Vol. 8, Iss. 3, pp. 47-47
Open Access | Times Cited: 147
Kratom—Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review
Steven Eastlack, Elyse M. Cornett, Alan D. Kaye
Pain and Therapy (2020) Vol. 9, Iss. 1, pp. 55-69
Open Access | Times Cited: 138
Kratom use and mental health: A systematic review
Marc T. Swogger, Zach Walsh
Drug and Alcohol Dependence (2017) Vol. 183, pp. 134-140
Closed Access | Times Cited: 133
Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7‐hydroxymitragynine
Scott E. Hemby, Scot McIntosh, Francisco León, et al.
Addiction Biology (2018) Vol. 24, Iss. 5, pp. 874-885
Closed Access | Times Cited: 128
<p>Current perspectives on the impact of Kratom use</p>
Charles A. Veltri, Oliver Grundmann
Substance Abuse and Rehabilitation (2019) Vol. Volume 10, pp. 23-31
Open Access | Times Cited: 127
Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program
Kirsten E. Smith, Thomas Lawson
Drug and Alcohol Dependence (2017) Vol. 180, pp. 340-348
Closed Access | Times Cited: 116
Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine
Alicia G. Lydecker, Abhisheak Sharma, Christopher R. McCurdy, et al.
Journal of Medical Toxicology (2016) Vol. 12, Iss. 4, pp. 341-349
Open Access | Times Cited: 113
Kratom policy: The challenge of balancing therapeutic potential with public safety
Walter C. Prozialeck, Bonnie A. Avery, Edward W. Boyer, et al.
International Journal of Drug Policy (2019) Vol. 70, pp. 70-77
Open Access | Times Cited: 92
Substance-related exogenous psychosis: a postmodern syndrome
Giovanni Martinotti, Luisa De Risio, Chiara Vannini, et al.
CNS Spectrums (2020) Vol. 26, Iss. 1, pp. 84-91
Open Access | Times Cited: 85
Characteristics of deaths associated with kratom use
John Corkery, Peter Streete, Hugh Claridge, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1102-1123
Open Access | Times Cited: 84
Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use
Kirsten E. Smith, Jeffrey M. Rogers, Destiny Schriefer, et al.
Drug and Alcohol Dependence (2021) Vol. 226, pp. 108879-108879
Open Access | Times Cited: 56
Understanding Kratom Use: A Guide for Healthcare Providers
Marc T. Swogger, Kirsten E. Smith, Albert Garcia‐Romeu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 52
Directed Biosynthesis of Mitragynine Stereoisomers
Carsten Schotte, Yindi Jiang, Dagny Grzech, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 9, pp. 4957-4963
Open Access | Times Cited: 32
Three years of wastewater surveillance for new psychoactive substances from 16 countries
Richard Bade, Nikolaos I. Rousis, Sangeet Adhikari, et al.
Water Research X (2023) Vol. 19, pp. 100179-100179
Open Access | Times Cited: 32
Ecological Momentary Assessment of Self-Reported Kratom Use, Effects, and Motivations Among US Adults
Kirsten E. Smith, Leigh V. Panlilio, Jeffrey D. Feldman, et al.
JAMA Network Open (2024) Vol. 7, Iss. 1, pp. e2353401-e2353401
Open Access | Times Cited: 14
Kratom safety and toxicology in the public health context: research needs to better inform regulation
Jack E. Henningfield, Oliver Grundmann, Marilyn A. Huestis, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of Mitragyna speciosa (kratom)
Shyam H. Kamble, Abhisheak Sharma, Tamara I. King, et al.
Xenobiotica (2018) Vol. 49, Iss. 11, pp. 1279-1288
Closed Access | Times Cited: 82
New psychoactive substances of natural origin: A brief review
Ling-Yi Feng, Altansuvd Battulga, Eunyoung Han, et al.
Journal of Food and Drug Analysis (2017) Vol. 25, Iss. 3, pp. 461-471
Open Access | Times Cited: 79
Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia
Darshan Singh, Suresh Narayanan, Balasingam Vicknasingam, et al.
Human Psychopharmacology Clinical and Experimental (2017) Vol. 32, Iss. 3
Open Access | Times Cited: 78
New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokinetics
Markus R. Meyer
Archives of Toxicology (2016) Vol. 90, Iss. 10, pp. 2421-2444
Closed Access | Times Cited: 69
The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations
Noreen Dadirai Mdege, Nick Meader, Charlie Lloyd, et al.
Public Health Research (2017) Vol. 5, Iss. 4, pp. 1-138
Open Access | Times Cited: 65
Newly Emerging Drugs of Abuse and Their Detection Methods
Li Liu, Sarah Wheeler, Raman Venkataramanan, et al.
American Journal of Clinical Pathology (2017) Vol. 149, Iss. 2, pp. 105-116
Open Access | Times Cited: 65
G protein‐biased kratom‐alkaloids and synthetic carfentanil‐amide opioids as potential treatments for alcohol use disorder
Anna M. Gutridge, Meridith T. Robins, Robert J. Cassell, et al.
British Journal of Pharmacology (2019) Vol. 177, Iss. 7, pp. 1497-1513
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top